Immunogenicity and safety of Southern Hemisphere inactivated quadrivalent influenza vaccine: a Phase III, open-label study of adults in Brazil

Cristiano A.F. Zerbini; Rodrigo Ribeiro dos Santos; Maria Jose Nunes; Jyoti Soni; Ping Li; Varsha K. Jain; Opokua Ofori-Anyinam

doi:10.1016/j.bjid.2016.10.003

Immunogenicity and safety of Southern Hemisphere inactivated quadrivalent influenza vaccine: a Phase III, open-label study of adults in Brazil

The Brazilian Journal of Infectious Diseases ◽

10.1016/j.bjid.2016.10.003 ◽

2017 ◽

Vol 21 (1) ◽

pp. 63-70 ◽

Cited By ~ 1

Author(s):

Cristiano A.F. Zerbini ◽

Rodrigo Ribeiro dos Santos ◽

Maria Jose Nunes ◽

Jyoti Soni ◽

Ping Li ◽

...

Keyword(s):

Influenza Vaccine ◽

Southern Hemisphere ◽

Phase Iii ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Quadrivalent Influenza Vaccine

Download Full-text

A phase III, randomized, open-label study to assess the tolerability and immunogenicity of an H5N1 influenza vaccine administered to healthy adults with a 1-, 2-, 3-, or 6-week interval between first and second doses

Clinical Therapeutics ◽

10.1016/s0149-2918(11)00024-5 ◽

2010 ◽

Vol 32 (13) ◽

pp. 2186-2197 ◽

Cited By ~ 17

Author(s):

Jiri Beran ◽

Ibrahim A. Abdel-Messih ◽

Jolana Raupachova ◽

Lenka Hobzova ◽

Elena Fragapane

Keyword(s):

Influenza Vaccine ◽

Healthy Adults ◽

Phase Iii ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

H5n1 Influenza

Download Full-text

A phase III/IV open-label study of the immunogenicity and safety of a single dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for each of three successive years in children naïve to, or in previous receipt of the AS03B adjuvanted H1N1 (2009)

http://isrctn.org/> ◽

10.1186/isrctn11725083 ◽

2014 ◽

Author(s):

Jo Southern

Keyword(s):

Single Dose ◽

Influenza Vaccine ◽

Phase Iii ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Live Attenuated Influenza Vaccine

Download Full-text

ENGOT-en9/LEAP-001: A phase III, randomized, active-controlled, open-label study of pembrolizumab plus lenvatinib versus paclitaxel plus carboplatin for newly diagnosed advanced or recurrent endometrial cancer

Gynecologic Oncology ◽

10.1016/j.ygyno.2020.05.366 ◽

2020 ◽

Vol 159 ◽

pp. 221

Author(s):

C. Marth ◽

C. Vulsteke ◽

M.J.R. Rubio ◽

V. Makker ◽

E.I. Braicu ◽

...

Keyword(s):

Endometrial Cancer ◽

Phase Iii ◽

Newly Diagnosed ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Recurrent Endometrial Cancer

Download Full-text

Improvement of Hemodialysis Catheter Function with Tenecteplase: A Phase III, Open-Label Study: TROPICS 4

Journal of Thrombosis and Thrombolysis ◽

10.1007/s11239-010-0493-1 ◽

2010 ◽

Vol 31 (1) ◽

pp. 99-106 ◽

Cited By ~ 1

Author(s):

Steven Fishbane ◽

Samuel L. Milligan ◽

Kenneth D. Lempert ◽

Joachim E. W. Hertel ◽

James B. Wetmore ◽

...

Keyword(s):

Phase Iii ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Hemodialysis Catheter ◽

Catheter Function

Download Full-text

Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study

Human Vaccines & Immunotherapeutics ◽

10.1080/21645515.2020.1796423 ◽

2020 ◽

pp. 1-8

Author(s):

Asmik Asatryan ◽

Nadia Meyer ◽

Michael Scherbakov ◽

Victor Romanenko ◽

Irina Osipova ◽

...

Keyword(s):

Pertussis Vaccine ◽

Vaccine Dose ◽

Acellular Pertussis Vaccine ◽

Phase Iii ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Booster Vaccine

Download Full-text

Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study

Hepatology International ◽

10.1007/s12072-017-9788-z ◽

2017 ◽

Vol 11 (2) ◽

pp. 188-198 ◽

Cited By ~ 2

Author(s):

Mark S. Sulkowski ◽

Walford J. Fessel ◽

Adriano Lazzarin ◽

Juan Berenguer ◽

Natalia Zakharova ◽

...

Keyword(s):

Pegylated Interferon ◽

Interferon Alfa ◽

Phase Iii ◽

Efficacy And Safety ◽

Genotype 1 ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Pegylated Interferon Alfa ◽

Hcv Genotype 1

Download Full-text

Immunogenicity, Safety, and Efficacy of Abatacept Administered Subcutaneously With or Without Background Methotrexate in Patients With Rheumatoid Arthritis: Results From a Phase III, International, Multicenter, Parallel-Arm, Open-Label Study

Arthritis Care & Research ◽

10.1002/acr.21876 ◽

2013 ◽

Vol 65 (5) ◽

pp. 718-728 ◽

Cited By ~ 48

Author(s):

Peter Nash ◽

Sauithree Nayiager ◽

Mark C. Genovese ◽

Alan J. Kivitz ◽

Kurt Oelke ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Phase Iii ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

International Multicenter

Download Full-text

Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Val30Met: A phase III, open-label study

Journal of the Neurological Sciences ◽

10.1016/j.jns.2016.01.046 ◽

2016 ◽

Vol 362 ◽

pp. 266-271 ◽

Cited By ~ 42

Author(s):

Yukio Ando ◽

Yoshiki Sekijima ◽

Konen Obayashi ◽

Taro Yamashita ◽

Mitsuharu Ueda ◽

...

Keyword(s):

Japanese Patients ◽

Familial Amyloid Polyneuropathy ◽

Phase Iii ◽

Efficacy And Safety ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Amyloid Polyneuropathy

Download Full-text

Abstract No. 253: A phase III, open-label study of tenecteplase for improvement of hemodialysis catheter function: TROPICS 4

Journal of Vascular and Interventional Radiology ◽

10.1016/j.jvir.2009.12.039 ◽

2010 ◽

Vol 21 (2) ◽

pp. S97 ◽

Cited By ~ 1

Author(s):

S. Fishbane ◽

S.L. Milligan ◽

K.D. Lempert ◽

J.E. Hertel ◽

J.B. Wetmore ◽

...

Keyword(s):

Phase Iii ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Hemodialysis Catheter ◽

Catheter Function

Download Full-text

168TiP KEYNOTE-A86: Phase III, randomized, open-label study of first-line subcutaneous (SC) vs intravenous (IV) pembrolizumab with platinum doublet chemotherapy in metastatic squamous or nonsquamous non-small cell lung cancer (NSCLC)

Annals of Oncology ◽

10.1016/j.annonc.2021.10.187 ◽

2021 ◽

Vol 32 ◽

pp. S1456

Author(s):

B. Halmos ◽

P. Cobb ◽

M.L. Johnson ◽

L. Jain ◽

S.J. Kim ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

First Line ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Doublet Chemotherapy ◽

Platinum Doublet

Download Full-text